Home Our Excellence Clinical Excellence

Clinical Excellence

Delivering trusted, high‑quality care through leading clinical expertise, advanced technologies and strong academic and hospital partnerships across Hong Kong and Shanghai. Our teams uphold rigorous standards of safety and excellence, ensuring patients receive evidence‑based, compassionate and world‑class medical care.

Partnership with The University of Hong Kong

Gleneagles Hospital Hong Kong is an affiliate teaching hospital of The University of Hong Kong (HKU), a unique private-academic partnership that spans clinical governance and services, medical education and research. Through the HKU Health System, HKU builds and oversees a robust clinical governance framework to ensure the hospital’s high clinical standards and its rigorous, integrated approach to quality and patient safety.

In close partnership with HKU, professoriates across various medical specialties and professionals in nursing and allied health from HKU provide clinical services at the hospital. Over the years, a number of professorial-led, multidisciplinary specialist service centres and a Professorial Clinic have been established to introduce advanced, novel treatments for patients.

As Hong Kong’s leading private teaching hospital, Gleneagles also plays an active role in advancing medical research. The partnership supports pioneering initiatives such as the jointly established Gleneagles Clinical Trials Centre, underscoring the shared commitment of Gleneagles and HKU in driving medical innovation and translating new discoveries into improved patient care and community health outcomes.

Strategic Clinical Collaboration with Shanghai General Hospital

Parkway Shanghai Hospital has established a formal strategic collaboration with Shanghai General Hospital, one of Shanghai’s oldest and most established Class III Grade A public hospitals. Through this partnership, both institutions work closely on the joint development of key clinical specialties and the creation of two way referral pathways that support seamless patient access to appropriate expertise. The collaboration also includes co management of complex cases, shared talent development and academic exchange, as well as the adoption of internationally aligned clinical pathways. Together, the two hospitals aim to co-develop a number of specialty centres, including areas such as hepatobiliary and pancreatic care, breast and thyroid services, urology, spine and cardiology, strengthening the overall clinical capabilities available to patients in the region.

Novel and Advanced Treatments

Across Hong Kong and Shanghai, IHH North Asia is committed to bringing the world’s most advanced and evidence‑based treatments to our patients. Through close collaboration with leading academic and clinical partners, we introduce innovative technologies and breakthrough therapies, from non‑invasive tumour treatments to multimodality cancer care, that enhance safety, precision and outcomes. Our specialist teams continually translate emerging medical advancements into real clinical practice, ensuring patients can access personalised, effective and cutting‑edge treatment options.

Histotripsy: Advanced Non-invasive Liver Tumour Treatment

Gleneagles Hospital Hong Kong is the first private hospital in Asia to offer Histotripsy treatment, the transformative and non-invasive technology that uses high-intensity ultrasound waves to destroy tumours for liver cancer patients.

"Reduce and Remove" Tri-modality Therapy

The “Reduce and Remove” Tri‑modality Therapy is an innovative approach for intermediate‑stage liver cancer patients who are initially unsuitable for surgery. By reducing tumour size through combined treatments, it may enable selected patients to become eligible for curative surgical resection, with fewer side effects and improved recovery.

ERAS (Enhanced Recovery After Surgery)

Gleneagles Hospital Hong Kong has adopted Enhanced Recovery After Surgery (ERAS) since its early days of operation. This fast‑track recovery approach follows a standardised clinical protocol designed to reduce surgical stress, minimise bleeding and effectively control pain. By optimising pain management and perioperative care, ERAS helps patients recover faster, regain mobility earlier and return to daily activities sooner.

Hyperthermic Intraperitoneal Chemotherapy (HIPEC)

HIPEC is a high-concentration treatment directed at treating certain types of cancer, in which heated chemotherapy is heated chemotherapy is applied directly into the abdomen after Cytoreductive surgery while the patient is still under anaesthesia. This approach allows higher drug concentrations to act on remaining cancer cells more effectively, with improved survival outcomes and no significant increase in complications.

Clinical Excellence

Partnership with The University of Hong Kong

Strategic Clinical Collaboration with Shanghai General Hospital

Novel and Advanced Treatments

Histotripsy: Advanced Non-invasive Liver Tumour Treatment

"Reduce and Remove" Tri-modality Therapy

ERAS (Enhanced Recovery After Surgery)

Hyperthermic Intraperitoneal Chemotherapy (HIPEC)

Contact Information

HOSPITALS

PRIMARY CARE

ANCILLARY SERVICES